BRCA1 and ovarian carcinoma: Finally, recent research has highlighted the potential significance of molecular biomarkers such as BRCA1/2, homologous recombination status (HR status), microsatellite instability (MSI), mismatch repair (MMR), and tumor mutational burden (TMB) in ovarian cancer[26].